Brief

On March 12, 2025, the Italian Medicines Agency (AIFA) initiated a public consultation on the document "Criteria for evaluation to attribute therapeutic innovativeness" and management of antibiotics for multi-resistant germ infections. The consultation is a preliminary step towards defining criteria for attributing therapeutic innovativeness by AIFA for access to the Innovative Medicine Fund, as per the Italian Law No. 207 of December 30, 2024.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies